BETRF (BetterLife Pharma) Interest Expense: $-0.06 Mil (TTM As of Apr. 2026)


BETRF BetterLife Pharma Inc BETRF
28 GF Score
Price $0.13
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Interest Expense?

BetterLife Pharma BETRF +11.06% 28 Interest Expense is $-0.06 Mil as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BetterLife Pharma's interest expense for the three months ended in Apr. 2026 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BetterLife Pharma's Operating Income for the three months ended in Apr. 2026 was $ -0.41 Mil. BetterLife Pharma's Interest Expense for the three months ended in Apr. 2026 was $ -0.02 Mil. BetterLife Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BetterLife Pharma  (OTCPK:BETRF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BetterLife Pharma's Interest Expense for the three months ended in Apr. 2026 was $-0.02 Mil. Its Operating Income for the three months ended in Apr. 2026 was $-0.41 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2026 was $0.02 Mil.

BetterLife Pharma's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as

BetterLife Pharma did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

BetterLife Pharma Interest Expense Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Interest Expense Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.05 -0.04 -0.22 -0.17

BetterLife Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 -0.06 -0.04 0.00 -0.02
BETRF
28GF Score
BetterLife Pharma Inc BETRF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.06 Mil mean?
BetterLife Pharma (BETRF) has a Interest Expense of $-0.06 Mil as of Apr. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Interest Expense too high?
BetterLife Pharma's current Interest Expense is $-0.06 Mil. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Interest Expense compare to VRTX and REGN?
BetterLife Pharma's Interest Expense of $-0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Interest Expense is $-0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Interest Expense of $-0.06 Mil. The current Interest Expense is $-0.06 Mil. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Interest Expense is $-0.06 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score

Get the complete analysis for BETRF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price